126 related articles for article (PubMed ID: 9292567)
1. Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle.
Amann K; Neimeier KA; Schwarz U; Törnig J; Matthias S; Orth SR; Mall G; Ritz E
Am J Kidney Dis; 1997 Sep; 30(3):382-8. PubMed ID: 9292567
[TBL] [Abstract][Full Text] [Related]
2. Nonhypotensive dose of beta-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure.
Amann K; Hofstetter J; Câmpean V; Koch A; Gross ML; Veelken R; Ritz E
Virchows Arch; 2006 Aug; 449(2):207-14. PubMed ID: 16691425
[TBL] [Abstract][Full Text] [Related]
3. Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure.
Amann K; Törnig J; Buzello M; Kuhlmann A; Gross ML; Adamczak M; Buzello M; Ritz E
Kidney Int; 2002 Sep; 62(3):877-84. PubMed ID: 12164869
[TBL] [Abstract][Full Text] [Related]
4. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine.
Törnig J; Amann K; Ritz E; Nichols C; Zeier M; Mall G
J Am Soc Nephrol; 1996 May; 7(5):667-75. PubMed ID: 8738800
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure.
Törnig J; Gross ML; Simonaviciene A; Mall G; Ritz E; Amann K
J Am Soc Nephrol; 1999 Jan; 10(1):77-83. PubMed ID: 9890312
[TBL] [Abstract][Full Text] [Related]
6. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.
Amann K; Nichols C; Tornig J; Schwarz U; Zeier M; Mall G; Ritz E
Nephrol Dial Transplant; 1996 Jun; 11(6):1003-11. PubMed ID: 8671960
[TBL] [Abstract][Full Text] [Related]
7. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
[TBL] [Abstract][Full Text] [Related]
8. Reduced capillary density in the myocardium of uremic rats--a stereological study.
Amann K; Wiest G; Zimmer G; Gretz N; Ritz E; Mall G
Kidney Int; 1992 Nov; 42(5):1079-85. PubMed ID: 1453595
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats.
Koleganova N; Piecha G; Ritz E; Gross ML
Nephrol Dial Transplant; 2009 Mar; 24(3):778-87. PubMed ID: 18829613
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte loss in experimental renal failure: prevention by ramipril.
Amann K; Tyralla K; Gross ML; Schwarz U; Törnig J; Haas CS; Ritz E; Mall G
Kidney Int; 2003 May; 63(5):1708-13. PubMed ID: 12675846
[TBL] [Abstract][Full Text] [Related]
11. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.
Amann K; Törnig J; Kugel B; Gross ML; Tyralla K; El-Shakmak A; Szabo A; Ritz E
Kidney Int; 2003 Apr; 63(4):1296-301. PubMed ID: 12631346
[TBL] [Abstract][Full Text] [Related]
12. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH.
Amann K; Törnig J; Flechtenmacher C; Nabokov A; Mall G; Ritz E
Nephrol Dial Transplant; 1995 Nov; 10(11):2043-8. PubMed ID: 8643165
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.
Kuhlmann A; Haas CS; Gross ML; Reulbach U; Holzinger M; Schwarz U; Ritz E; Amann K
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F526-33. PubMed ID: 14600034
[TBL] [Abstract][Full Text] [Related]
14. Capillary/myocyte mismatch in the heart in renal failure--a role for erythropoietin?
Amann K; Buzello M; Simonaviciene A; Miltenberger-Miltenyi G; Koch A; Nabokov A; Gross ML; Gless B; Mall G; Ritz E
Nephrol Dial Transplant; 2000 Jul; 15(7):964-9. PubMed ID: 10862632
[TBL] [Abstract][Full Text] [Related]
15. [Permissive effect of PTH on vascular wall hypertrophy of intramyocardial arteries in experimental renal failure].
Amann K; Flechtenmacher C; Törnig J; Schwarz U; Mall G; Ritz E
Med Klin (Munich); 1996 Sep; 91(9):551-6. PubMed ID: 8984312
[TBL] [Abstract][Full Text] [Related]
16. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E
J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093
[TBL] [Abstract][Full Text] [Related]
17. Cardiac remodelling in experimental renal failure--an immunohistochemical study.
Amann K; Kronenberg G; Gehlen F; Wessels S; Orth S; Münter K; Ehmke H; Mall G; Ritz E
Nephrol Dial Transplant; 1998 Aug; 13(8):1958-66. PubMed ID: 9719148
[TBL] [Abstract][Full Text] [Related]
18. Increased infarct size in uremic rats: reduced ischemia tolerance?
Dikow R; Kihm LP; Zeier M; Kapitza J; Törnig J; Amann K; Tiefenbacher C; Ritz E
J Am Soc Nephrol; 2004 Jun; 15(6):1530-6. PubMed ID: 15153563
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors.
Ogata H; Ritz E; Odoni G; Amann K; Orth SR
J Am Soc Nephrol; 2003 Apr; 14(4):959-67. PubMed ID: 12660330
[TBL] [Abstract][Full Text] [Related]
20. Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats.
Morath C; Ratzlaff K; Dechow C; Schwenger V; Schaier M; Zeier B; Peters J; Tsukada M; Zouboulis CC; Waldherr R; Gross ML; Ritz E; Zeier M; Wagner J
J Mol Med (Berl); 2009 Jan; 87(1):53-64. PubMed ID: 18795249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]